ATE178909T1 - Inhibitor peptid spezifisch für cathepsin-l - Google Patents

Inhibitor peptid spezifisch für cathepsin-l

Info

Publication number
ATE178909T1
ATE178909T1 AT94931695T AT94931695T ATE178909T1 AT E178909 T1 ATE178909 T1 AT E178909T1 AT 94931695 T AT94931695 T AT 94931695T AT 94931695 T AT94931695 T AT 94931695T AT E178909 T1 ATE178909 T1 AT E178909T1
Authority
AT
Austria
Prior art keywords
cathepsin
polypeptide
inhibitor peptide
peptide specific
inhibitor
Prior art date
Application number
AT94931695T
Other languages
English (en)
Inventor
Nobuhiko Katsunuma
Vito Turk
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ATE178909T1 publication Critical patent/ATE178909T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT94931695T 1993-11-12 1994-11-08 Inhibitor peptid spezifisch für cathepsin-l ATE178909T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28327093 1993-11-12
JP31353393A JP3276753B2 (ja) 1993-11-12 1993-12-14 カテプシンｌ特異的阻害ポリペプチド

Publications (1)

Publication Number Publication Date
ATE178909T1 true ATE178909T1 (de) 1999-04-15

Family

ID=26554960

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94931695T ATE178909T1 (de) 1993-11-12 1994-11-08 Inhibitor peptid spezifisch für cathepsin-l

Country Status (11)

Country Link
US (1) US5698519A (de)
EP (1) EP0679659B1 (de)
JP (1) JP3276753B2 (de)
KR (1) KR950704358A (de)
AT (1) ATE178909T1 (de)
AU (1) AU671783B2 (de)
CA (1) CA2151059A1 (de)
DE (1) DE69417872T2 (de)
HU (1) HU214343B (de)
NO (1) NO952748D0 (de)
WO (1) WO1995013302A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2481489A1 (en) * 2002-11-29 2004-06-17 Morinaga Milk Industry Co., Ltd. Cysteine protease inhibitor
WO2004084830A2 (en) * 2003-03-21 2004-10-07 Buck Institute Method for treating alzheimer’s dementia
WO2008045017A2 (en) * 2005-06-22 2008-04-17 Diamond Scott L Sars and ebola inhibitors and use thereof, and methods for their discovery
US20080227688A1 (en) * 2007-03-13 2008-09-18 Johnston Randal N Inhibition of viral replication

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3938971A1 (de) * 1989-11-24 1991-05-29 Biotechnolog Forschung Gmbh Leukozytenelastase und kathepsin g blockierendes peptid, dna, vektor, wirtsorganismus und verfahren zu seiner gewinnung sowie pharmazeutisches praeparat

Also Published As

Publication number Publication date
EP0679659B1 (de) 1999-04-14
NO952748L (no) 1995-07-11
US5698519A (en) 1997-12-16
AU8067494A (en) 1995-05-29
DE69417872T2 (de) 1999-08-12
DE69417872D1 (en) 1999-05-20
CA2151059A1 (en) 1995-05-18
HU9501580D0 (en) 1995-09-28
HUT73415A (en) 1996-07-29
WO1995013302A1 (en) 1995-05-18
JP3276753B2 (ja) 2002-04-22
NO952748D0 (no) 1995-07-11
JPH07179496A (ja) 1995-07-18
HU214343B (hu) 1998-03-02
EP0679659A4 (de) 1996-05-22
EP0679659A1 (de) 1995-11-02
AU671783B2 (en) 1996-09-05
KR950704358A (ko) 1995-11-20

Similar Documents

Publication Publication Date Title
FR2744134B1 (fr) Proteines de reserve de plantes enrichies en acides amines, notamment alpha-zeine de mais enrichie en lysine plantes exprimant ces proteines
GR3019901T3 (en) Osteoinductive pharmaceutical formulations
EP0235205A4 (de) Peptidanalogedes insulinähnlichen wachstumsfaktors-1 bei säugetieren.
SE9101838D0 (sv) Novel peptides and their use
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
DE69029377D1 (de) Substituierungsanaloge von magaininpeptiden
NO971621L (no) Keratinocyttvekstfaktoranaloger
EP0498784A3 (en) Inhibitors of retroviral protease
ATE178909T1 (de) Inhibitor peptid spezifisch für cathepsin-l
HU9301726D0 (en) Compounds and preparatives hindering resorption of bones
BR9506038A (pt) Dna clonato vetor recombinante e planta
NO20012232L (no) Enzymatisk amidering av peptider
EP0643075A4 (de) Neue peptide mit elastase inhibitorwirkung und verfahren zur herstellung davon.
NZ511618A (en) Kininogen fragment 2 peptides with the formula of at least X-His-Lys-X-Lys-X
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
SG64917A1 (en) Method of peptide synthesis and new synthesis intermediates
DE69613489D1 (de) Antibiotische peptide aus der kuhmilch
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
DE3665462D1 (en) Pharmacologically active peptides
MY119431A (en) (het)arysulfonylureas having an amino function, their preparation and their use as herbicides and plant growth regulators
EP1295943A4 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
ES2052447A1 (es) Peptidos hemorreguladores.
GB0008504D0 (en) Novel polypeptide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties